These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Non-thyroidal side effects of amiodarone]. Creplet J Rev Med Brux; 1996 Sep; 17(4):198-202. PubMed ID: 8927844 [TBL] [Abstract][Full Text] [Related]
44. Amiodarone and dronedarone: An update. Vamos M; Hohnloser SH Trends Cardiovasc Med; 2016 Oct; 26(7):597-602. PubMed ID: 27155812 [TBL] [Abstract][Full Text] [Related]
45. Study of warfarin utilization in hospitalized patients: analysis of possible drug interactions. Guidoni CM; Camargo HP; Obreli-Neto PR; Girotto E; Pereira LR Int J Clin Pharm; 2016 Oct; 38(5):1048-51. PubMed ID: 27365092 [TBL] [Abstract][Full Text] [Related]
46. Warfarin potentiation: a review of the "FAB-4" significant drug interactions. Thi L; Shaw D; Bird J Consult Pharm; 2009 Mar; 24(3):227-30. PubMed ID: 19555137 [TBL] [Abstract][Full Text] [Related]
47. An evaluation of the early pharmacodynamic response after simultaneous initiation of warfarin and amiodarone. Edwin SB; Jennings DL; Kalus JS J Clin Pharmacol; 2010 Jun; 50(6):693-8. PubMed ID: 20081064 [TBL] [Abstract][Full Text] [Related]
48. Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long-term therapy. Sanoski CA; Bauman JL Chest; 2002 Jan; 121(1):19-23. PubMed ID: 11796427 [TBL] [Abstract][Full Text] [Related]
49. I was told to stop taking my daily betablocker (Coreg)before a myocardial perfusion test. I was hospitalized with chest pain and a bout of atrial fibrillation. I have cardiomyopathy and was prescribed amiodarone and warfarin, but I stopped taking them when I learned of their side effects. Was it wrong to stop taking the Coreg? Heart Advis; 2008 Aug; 11(8):8. PubMed ID: 18822516 [No Abstract] [Full Text] [Related]
52. [Amiodarone and the thyroid]. Pavan R; Jesus AM; Maciel LM Arq Bras Endocrinol Metabol; 2004 Feb; 48(1):176-82. PubMed ID: 15611831 [TBL] [Abstract][Full Text] [Related]
53. Characteristics of the amiodarone-warfarin interaction during long-term follow-up. Lu Y; Won KA; Nelson BJ; Qi D; Rausch DJ; Asinger RW Am J Health Syst Pharm; 2008 May; 65(10):947-52. PubMed ID: 18463344 [TBL] [Abstract][Full Text] [Related]
54. Amiodarone-induced thrombosis: a case series and brief review of the literature. Iqbal FM; Chawla B; Koneru J; Bikkina M Am J Ther; 2012 Sep; 19(5):389-91. PubMed ID: 21150769 [TBL] [Abstract][Full Text] [Related]
55. Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation. Catherwood E; Fitzpatrick WD; Greenberg ML; Holzberger PT; Malenka DJ; Gerling BR; Birkmeyer JD Ann Intern Med; 1999 Apr; 130(8):625-36. PubMed ID: 10215558 [TBL] [Abstract][Full Text] [Related]
56. A case of pseudocyanotic coloring of skin after prolonged use of amiodarone. Ioannides MA; Moutiris JA; Zambartas C Int J Cardiol; 2003 Aug; 90(2-3):345-6. PubMed ID: 12957776 [No Abstract] [Full Text] [Related]
57. Dangers of amiodarone and anticoagulant treatment. Rees A; Dalal JJ; Reid PG; Henderson AH; Lewis MJ Br Med J (Clin Res Ed); 1981 May; 282(6278):1756-7. PubMed ID: 6786610 [No Abstract] [Full Text] [Related]